Introduction
Helicobacter pylori is a widespread microorganism and it has been reported that more than half of the world's population is infected with the bacterium (1). The prevalence rate was found to be 86% in Turkey (2) . H. pylori colonises in the mucus layer of the human stomach and is well accepted as the causative agent of chronic gastritis, peptic ulcers, mucosa associated lymphoid tissue lymphoma, and gastric cancer (3) . Several H. pylori virulence genes that play a role in the pathogenesis of the disease have been identified. The vacuolating cytotoxin and cytotoxin-associated protein, encoded by vacuolating cytotoxin A (vacA) and cytotoxin-associated gene A (cagA), respectively are important virulence determinants of H. pylori (4, 5) . The cagA is reported to be found in more than half of the H. pylori isolates. It is known that cagA is a marker for the cag pathogenicity island and is associated with increased IL-8 production, nuclear factor-kB activation, mucosal inflammation and development of peptic ulcers, atrophic gastritis, and gastric cancer (6) . The vacA gene encodes an 87-93 kDa molecular weight VacA protein, which induces cytoplasmic vacuoles in mammalian cells. Unlike the cagA, all H. pylori strains possess the vacA gene but only half of them can produce biologically active toxin. This condition is mostly attributed to sequence differences in the signal region (s1, s2) and middle region (m1, m2). Any combinations of these allelic subtypes can be observed, although the vacA s2m1 genotype is uncommon (5) . It has been reported that strains possessing vacA s1 and m1 genotypes are more virulent than those carrying vacA s2 and m2. Furthermore, type vacA s1a strains were reported to show more toxin activity than vacA s1b, while type s2 has no detectable toxin activity and is mostly found to be associated with ulcer disease (5, 7, 8) .
It has been well accepted that the presence of cagA and the distribution of vacA allelic subtypes demonstrate a significant geographical variation (5) . In the present retrospective study, we aimed to determine the cagA prevalence and vacA allelic subtype frequencies and their association with clinical outcomes in a region of Turkey.
Methods

Sample size
The subjects of this study were 120 previously untreated patients seen at outpatient clinics of the Gastroenterology Department of Hacettepe University between January 2000 and January 2009. A total of 120 H. pylori strains from stock cultures, which had been isolated between the years 2000 and 2009, were randomly included in the present study. The endoscopic and histopathological findings and demographical variables of the patients were reviewed retrospectively. Only 80 of the patients' data were available in terms of histopathological findings. The study was approved by the ethics committee.
Isolation of H. pylori
One antral biopsy specimen of each patient was used for the isolation of the H. pylori. Brain Heart Infusion Agar (Oxoid), which was supplemented with 7% horse blood and antibiotics (vancomycin 6 g/mL, trimethoprim 2.5 g/mL) was used for the culturing process. After the inoculation of biopsy samples, the plates were incubated in a microaerophilic atmosphere at 37 °C (BBL GasPak System). After the incubation period (48-72 h), colonies of H. pylori were identified both by urease, catalase, and oxidase test positivity and by observing characteristic microscopical morphology by Gram staining. The stock cultures were prepared from tryptic soy broth with 20% glycerol and glass beads and were stored at -80 °C until used.
2.3. PCR-based genotyping of cagA and vacA DNA extraction was performed directly from stock cultures. A number of glass beads were taken into 300 µL of Tris-EDTA buffer (10 mM Tris HCl and 1 mM EDTA) and stored at -20 °C until processed. A standard cetyltrimethylammonium bromide (CTAB) genomic DNA isolation method was performed as previously described (9) . The sequence of the primers used in this study is represented in Table 1 .
In order to ascertain the presence of H. pylori DNA in stock cultures, the H. pylori-specific ureA gene was detected by polymerase chain reaction (PCR). A total of 120 samples positive for the ureA gene were further processed for the amplification of cagA and vacA alleles (s1a, s1b, s2, m1, and m2).
PCR reactions were performed with 25 µL of reaction mixture containing 2 µL of DNA template in a thermocycler device (MJ Research, Waltham, MA, USA). For the amplification of 411-bp fragments of the ureA gene, HPU1 and HPU2 primers were used (10) . PCR consisted of 35 cycles of 1 min of denaturating step at 94 °C, 1 min of annealing step at 48 °C, and 1 min of elongation step at 72 °C, with a first cycle of 2 min at 95 °C and a final cycle of 5 min at 72 °C. For the detection of cagA, a 348-bp internal fragment of the gene was amplified using the F1 and B1 primers. The PCR program for cagA amplification was: 95 °C, 5 min, 1 cycle; followed by 35 cycles of 94 °C for 30 s (denaturation), 55 °C for 1 min (annealing), and 72 °C for 2 min (polymerisation); and 1 cycle at 72 °C for 5 min. The primers and conditions for the amplification of vacA allelic subtypes were those used by Atherton et al. (5) . The amplified products were analysed on 2% agarose gel, stained with ethidium bromide, and visualised under UV light in order to determine the presence of specific fragments of the cagA and vacA allelic subtypes. H. pylori ATCC 43504 was used as a positive control. Each sample was studied twice to confirm the accuracy of the results. Table 1 . PCR primers used in this study.
Target
Primer name Sequence of the primers (5' -3') Size of PCR products
Statistical analyses
Statistical analyses were performed with SPSS 11.0 for Windows. In addition to the descriptive statistics, the groups were compared using the chi-square test. In the case of the presence of small data sets, the comparisons between the groups were performed by Monte Carlo exact test. P < 0.05 was considered statistically significant.
Results
Of the 120 H. pylori strains, 84 (70%) of them had been isolated from children, whereas 36 (30%) of them were from adults; the mean ages of these groups were 12.37 ± 2.94 years and 42.13 ± 18.95 years, respectively. All of the 120 strains included in the study were positive for the ureA gene. A total of 64 samples (53.3%) were found to be positive for cagA. However, there was no relationship between children and adults regarding cagA positivity (P = 0.472). Furthermore, no significant relationship was found between endoscopic and histopathological findings and cagA positivity (P = 0.741 and 0.554, respectively; Table 2 ).
Among 120 samples positive for ureA, neither vacA s nor vacA m regions could be amplified in 5 strains. In 8 samples the vacA s region and in 2 samples the vacA m region could not be determined. Both vacA m1 and m2 regions were detected together in 1 strain (0.9%). Thirty-eight (33.6%) strains had vacA m1 and 74 (65.5%) had vacA m2 region. Overall, 75 (70.1%) samples were classified as vacA s1a, 3 (2.8%) as vacA s1b, and 29 (27.1%) as vacA s2. There was no significant relationship between vacA genotypes and either endoscopic or histopathological findings.
When the results were evaluated in terms of overall vacA genotype, it was determined that vacA s1am1, s1am2, s1bm1, s1bm2, and s2m2 genotypes were detected in 33.6%, 35.6%, 1.0%, 1.9%, and 27.9% of the strains, respectively. None of the H. pylori strains were carrying the s2m1 genotype. The distribution of vacA genotypes according to endoscopic and histopathological findings is represented in Table 3 .
Among cagA positive strains, 86.9% had the vacA s1a subtype, whereas only 11.5% strains had vacA s2 and 1.6% had vacA s1b subtypes. Furthermore, it was demonstrated that cagA positivity was significantly related with vacA s1am1 genotype (P < 0.001). In total, 48.3% of the cagA positive strains were classified as vacA s1am1 genotype, and 12.1% of them were classified as vacA s2m2 genotype (Table 4) . Thus, in the present study we investigated the cagA prevalence and vacA allelic subtypes retrospectively and evaluated their relationships with clinical outcomes in strains that had been isolated at Hacettepe University Hospital. Table 5 summarises the vacA s and m genotype rates in the present study and in other studies from Turkey (7, (12) (13) (14) (15) (16) (17) . It has been known that cagA positivity rates and their association with clinical outcomes differ from region to region. In general, the cagA prevalence rate has been found to be between 50% and 60% in Middle Eastern countries, whereas in the East Asian countries almost all isolated strains are cagA-positive (18) . In Turkey, Saltık et al. (19) reported the cagA positivity rate as 55.6% in 45 isolates and they found no significant difference between the cagA positivity and the severity of the gastroduodenal symptoms. Our present findings, regarding a determination of a cagA positivity rate of 53.3% and no association between endoscopic findings and cagA status, are similar to those of Saltık et al. (19) . In another study from Turkey, Safak et al. reported the cagA prevalence rate as 36.3% (20) . Such an association has previously been reported, especially in Western isolates (21) . However, this relationship could not be determined in strains isolated from Asian countries (22, 23) . On the other hand, in a current study from Turkey, Karaman et al. reported a cagA positivity rate of 65.5% and they also found a significant relationship between cagA status and peptic ulcer disease (17) .
The different combinations of vacA s and m regions identify the virulence characteristic of the H. pylori strains. It has been reported that type s1m1 strains produce a higher cytotoxin activity in vitro than type s1m2 strains, while s2m2 strains, which are considered as less virulent strains, produce no detectable cytotoxin. Thus, identification of the vacA profiles of the isolated strains and evaluation of these subtype combinations together with the clinical outcome of the patients is of significant importance.
In accordance with the previous reports from Turkey, we found vacA s1a as the predominant vacA s subtype with a rate of 70.1% (7, 13, 24) . According to the reports from East Asian countries, all H. pylori strains isolated from East Asian countries are vacA s1 and cagA-positive, where the gastric cancer incidence has been reported in higher rates (25) . This finding supports the idea that the strains with vacA s1 genotypes secrete the toxin more effectively from the cell and strains with both vacA s1 and cagA cause more serious gastrointestinal symptoms (8) . Moreover, most of the vacA s1 strains are also cagA-positive (26) . In the present study we found that 52 of the 59 cagApositive strains were carrying the vacA s1 type, consistent with the literature. There was no association between the vacA s1 genotype and endoscopic findings. Our results are consistent with other reports from Turkey (7, 12) . However, in their study, Erzin et al. (14) reported an association between vacA s1a positive strains and duodenal ulcer and gastric cancer.
The association between the vacA m region and clinical outcome is still unclear. Such an association was reported in a few studies from Eastern and Middle Eastern countries (27) . Salehi et al. (28) reported the vacA m1 and m2 rates as 40% and 60%, respectively, in an Iranian population. They also found an association between vacA m1 genotype and gastroduodenal pathology. We found the vacA m2 genotype as predominant with a rate of 65.5%.
Our findings are in contrast with the results of Erzin et al. (14) and Aydin et al. (12) , who reported the vacA m1 and m2 genotypes with an almost equal presence. However, Saribasak et al. (7) reported the predominant vacA m subtype as m2 (77.8%) and found no association between vacA m genotypes and the development of peptic ulcer. According to our present results, the vacA profile of Turkey is similar with those of Middle Eastern countries, where the vacA s1 and m2 subtypes have been reported to be predominant subtypes in many studies (28, 29) .
According to the results of the large metaanalysis study by Sugimoto et al. (30) , in the combination of vacA s and m region genotypes, the predominant genotype was found to be vacA s1m2 (44.8%) in the North Middle East considering data from Turkey, Iran, and Iraq. In the same study, the overall rates of vacA s1m1, s2m1, and s2m2 were reported as 34.0%, 1.7%, and 19.5%, respectively. However, no previous studies had examined the subtypes of vacA s1 from these countries. In the study from Turkey by Erzin et al. (14) , the vacA s1 subtypes were also examined, and they reported the vacA s1am2 as predominant. Consistently with the data from Middle East countries and from Turkey, we found the predominant vacA genotype as s1am2 (35.6%). However, the frequencies of vacA s1am1 and s1am2 were almost same, with the rates of 33.6% and 35.6%, respectively. Moreover, we found the rate of vacA s2m2, the less virulent type, as 27.9%. None of the strains were carrying the vacA s2m1 genotype, consistent with the literature (5).
According to the previous reports from Asian countries, the predominant strains were reported to be vacA s1cm1 and s1cm2 (11, 31) . The vacA s1c subtype was first identified by Van Doorn et al. (32) in strains isolated from East Asian countries. Since there were no reports from Turkey and Middle Eastern countries regarding the presence of the vacA s1c subtype, it was not investigated in the present study.
The relationship between the presence of cagA and the vacA s1 region was first described by Atherton et al. (5) . In a recent study from Turkey, Nagiyev et al. (33) reported an association between more virulent vacA genotypes and cagA positivity. In the present study, as well, we found that 48.3% of the cagA-positive strains were carrying the more virulent vacA s1am1 genotype, whereas only 12.1% of those had the less virulent vacA s2m2 genotype. Thus, the vacA s1am1 genotype was found to be significantly associated with the presence of cagA. Moreover, among 28 patients harbouring more virulent cagA+ / vacA s1am1 isolates, 26 of them were in the gastritis, gastroduodenitis, or esophagitis group, indicating that the genotype vacA s1m1 and its association with the cagA positivity increase the risk of developing more severe gastric lesions. Such an association was also demonstrated by Andreson et al. (34) from Estonia, who reported the predominant genotype as vacA s1am1 and indicated a significant association of cagA positivity with vacA s1am1 and s1am2. In Turkey this association was reported by Karaman et al. (17) . They found that all 16 strains with the s1m1 genotype were also cagA-positive.
In contrast with the studies reporting the association of clinical outcomes with H. pylori virulence genes, especially with cagA status, we did not show such an association of endoscopic findings with either cagA or vacA gene status.
Interestingly, this is in agreement with the majority of other reports from Turkey, in which cagA prevalence rates were also found between 55% and 69% (17, 19) . Moreover, although the majority of the isolated H. pylori strains are cagA-positive in Asian countries, associations of cagA status and disease outcome are not encountered in this region (35) . This association was also not demonstrated in studies conducted on Iranian populations (36, 37) .
In the present study, we aimed to determine the cagA prevalence, vacA subtypes, and their associations with clinical findings in Turkey. To the best of our knowledge, there are limited reports from this region regarding the cagA and vacA status of Turkey. This study may contribute to the regional findings, since the geographical data in this issue are of significant importance.
In conclusion, we determined the cagA prevalence rate as 53.3% and the vacA predominant subtype as s1am2. However, no association was determined between clinical outcomes and virulence genotypes. A significant association between cagA positivity and vacA s1am1 genotype was found, in accordance with the previous reports in the literature.
In the light of the present results, it can be said that the data from Turkey are consistent with the Middle Eastern profile regarding cagA positivity, vacA status, and their associations with clinical outcomes. Further studies with larger sample sizes are needed in order to clarify the cagA and vacA profile of Turkey.
